Der MrgD-Rezeptor und seine Rolle in der Leberfibrose und deren Komplikationen im transgenen Tiermodell

No abstract is available for this paper.

• Publication year

  2020

• Venue

  Unknown venue

• Publication date

  2020-05-05

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatitis C virus: Morphogenesis, infection and therapy

  2018cited by this paper
• Dimerization of AT2 and Mas Receptors in Control of Blood Pressure

  2018cited by this paper
• Mouse and Rat Models of Induction of Hepatic Fibrosis and Assessment of Portal Hypertension.

  2017influential reference
• The status of hepatitis B control in the African region

  2017cited by this paper
• Evidence for Heterodimerization and Functional Interaction of the Angiotensin Type 2 Receptor and the Receptor MAS

  2017influential reference
• Method for Picrosirius Red-Polarization Detection of Collagen Fibers in Tissue Sections.

  2017influential reference
• Isolation and Culture of Primary Murine Hepatic Stellate Cells.

  2017cited by this paper
• Angiotensin A/Alamandine/MrgD Axis: Another Clue to Understanding Cardiovascular Pathophysiology

  2016influential reference
• The calcium-activated potassium channel KCa3.1 is an important modulator of hepatic injury

  2016cited by this paper
• Mini-Osmotic Pump Infusion Model to Investigate the Systemic Effects of Chronic Continuous Exposure to Staphylococcal Superantigen in Mice.

  2016cited by this paper
• Angiotensin-(1–7) abrogates angiotensin II-induced proliferation, migration and inflammation in VSMCs through inactivation of ROS-mediated PI3K/Akt and MAPK/ERK signaling pathways

  2016influential reference
• The compensatory renin–angiotensin system in the central regulation of arterial pressure: new avenues and new challenges

  2015cited by this paper
• Pathobiology of liver fibrosis: a translational success story

  2015influential reference
• Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments.

  2015influential reference
• Chronic passive venous congestion drives hepatic fibrogenesis via sinusoidal thrombosis and mechanical forces

  2015cited by this paper
• The carbon tetrachloride model in mice

  2015influential reference
• An angiotensin-(1-7) peptidase in the kidney cortex, proximal tubules, and human HK-2 epithelial cells that is distinct from insulin-degrading enzyme.

  2015cited by this paper
• Lack of weight gain after angiotensin AT1 receptor blockade in diet‐induced obesity is partly mediated by an angiotensin‐(1–7)/Mas‐dependent pathway

  2015cited by this paper
• Presentation and complications associated with cirrhosis of the liver

  2015cited by this paper
• Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

  2015cited by this paper
• Future therapy of portal hypertension in liver cirrhosis – a guess

  2014cited by this paper
• Inflammation and portal hypertension - the undiscovered country.

  2014influential reference
• New Components of the Renin-Angiotensin System: Alamandine and the Mas-Related G Protein-Coupled Receptor D

  2014cited by this paper
• Reduction of angiotensin A and alamandine vasoactivity in the rabbit model of atherogenesis: differential effects of alamandine and Ang(1‐7)

  2014cited by this paper
• Stage of Cirrhosis Predicts Risk of Liver Related Death in Low MELD Patients with Cirrhosis Awaiting Liver Transplant

  2014cited by this paper
• Pharmacology and Signaling of MAS-Related G Protein–Coupled Receptors

  2014cited by this paper
• The renin–angiotensin system: a possible contributor to migraine pathogenesis and prophylaxis

  2014cited by this paper
• Mas and Its Related G Protein–Coupled Receptors, Mrgprs

  2014influential reference
• Extracellular Matrix Modulates Angiogenesis in Physiological and Pathological Conditions

  2014cited by this paper
• Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions.

  2014cited by this paper
• Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis

  2014influential reference
• Report Title: The burden of liver disease in Europe: a review of available epidemiological data

  2013cited by this paper
• In vitro cell migration and invasion assays.

  2013cited by this paper
• Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study.

  2013cited by this paper
• Activation of the MAS receptor by angiotensin-(1-7) in the renin-angiotensin system mediates mesenteric vasodilatation in cirrhosis.

  2013cited by this paper
• Monitoring gene expression: quantitative real-time rt-PCR.

  2013cited by this paper
• Expression and distribution patterns of Mas-related gene receptor subtypes A–H in the mouse intestine: inflammation-induced changes

  2013cited by this paper
• Angiotensin-(1-7)-induced activation of ERK1/2 is cAMP/protein kinase A-dependent in glomerular mesangial cells.

  2012cited by this paper
• MRGD, a MAS-related G-protein Coupled Receptor, Promotes Tumorigenisis and Is Highly Expressed in Lung Cancer

  2012cited by this paper
• Reversibility of liver fibrosis

  2012cited by this paper
• Deactivation of hepatic stellate cells during liver fibrosis resolution in mice.

  2012cited by this paper
• Angiotensin (1-7) Induces Mas Receptor Internalization

  2011influential reference
• Hepatic encephalopathy: A central neuroinflammatory disorder?

  2011cited by this paper
• Heterodimerization of β2 adrenergic receptor and somatostatin receptor 5: Implications in modulation of signaling pathway

  2011cited by this paper
• A new look at the renin-angiotensin system--focusing on the vascular system.

  2011influential reference
• Noninvasive Evaluation of Liver Fibrosis in Patients with Chronic Hepatitis C

  2011influential reference
• Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

  2010cited by this paper
• Blood-brain barrier breakdown-inducing astrocytic transformation: novel targets for the prevention of epilepsy.

  2009influential reference
• Role of β3‐adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis

  2009cited by this paper
• Portal pressure responses and angiotensin peptide production in rat liver are determined by relative activity of ACE and ACE2.

  2009cited by this paper
• Renin-angiotensin system in the pathogenesis of liver fibrosis.

  2009influential reference
• The management of portal hypertension: rational basis, available treatments and future options.

  2008influential reference
• The liver sinusoidal endothelial cell: a cell type of controversial and confusing identity.

  2008cited by this paper
• Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver.

  2008cited by this paper
• Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system.

  2007influential reference
• The renin-angiotensin system in a rat model of hepatic fibrosis: evidence for a protective role of Angiotensin-(1-7).

  2007influential reference
• Mass-Spectrometric Identification of a Novel Angiotensin Peptide in Human Plasma

  2006cited by this paper
• Hepatic fibrosis, stellate cells, and portal hypertension.

  2006cited by this paper
• How many drug targets are there?

  2006cited by this paper
• Interactions between the Mas-Related Receptors MrgD and MrgE Alter Signalling and Trafficking of MrgD

  2006influential reference
• Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II.

  2006cited by this paper
• Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies.

  2006cited by this paper
• Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review.

  2006cited by this paper
• Collagen gel contraction assay.

  2006cited by this paper
• Liver Fibrogenesis: A New Role for the Renin–Angiotensin System

  2005cited by this paper
• Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis.

  2005cited by this paper
• Functional antagonism of different G protein-coupled receptor kinases for beta-arrestin-mediated angiotensin II receptor signaling.

  2005cited by this paper
• MELD vs Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis.

  2005cited by this paper
• The impact of G‐protein‐coupled receptor hetero‐oligomerization on function and pharmacology

  2005cited by this paper
• Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss

  2004cited by this paper
• Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice.

  2004cited by this paper
• Lamivudine for patients with chronic hepatitis B and advanced liver disease.

  2004cited by this paper
• Apoptosis: The nexus of liver injury and fibrosis

  2004cited by this paper
• Identification of a G Protein-coupled Receptor Specifically Responsive to β-Alanine*

  2004cited by this paper
• Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas

  2003cited by this paper
• Atypical expansion in mice of the sensory neuron-specific Mrg G protein-coupled receptor family

  2003cited by this paper
• Projecting future complications of chronic hepatitis C in the United States

  2003cited by this paper
• Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II.

  2003influential reference
• Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver.

  2003influential reference
• Functional Interplay Between Angiotensin II and Nitric Oxide: Cyclic GMP as a Key Mediator

  2003cited by this paper
• Liver fibrosis -- from bench to bedside.

  2003influential reference
• [Mechanisms of hepatic fibrogenesis].

  2002cited by this paper
• Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver.

  2002cited by this paper
• Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C.

  2002cited by this paper
• The paradox of nitric oxide in cirrhosis and portal hypertension: Too much, not enough

  2002cited by this paper
• Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase*

  2002cited by this paper
• Cooperation of Liver Cells in Health and Disease

  2001cited by this paper
• A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons.

  2001cited by this paper
• Rho family proteins: coordinating cell responses.

  2001cited by this paper
• Selective Angiotensin II Receptor Antagonism Reduces Insulin Resistance in Obese Zucker Rats

  2001cited by this paper
• Interactions between Hepatic Stellate Cells and the Immune System

  2001cited by this paper
• Candesartan Inhibits Carotid Intimal Thickening and Ameliorates Insulin Resistance in Balloon-Injured Diabetic Rats

  2001cited by this paper
• Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct.

  2001cited by this paper
• A model to predict survival in patients with end‐stage liver disease

  2001cited by this paper
• Angiotensin-(1-7): an update.

  2000cited by this paper
• NAD(P)H oxidase: role in cardiovascular biology and disease.

  2000cited by this paper
• Role of endocytosis in the activation of the extracellular signal-regulated kinase cascade by sequestering and nonsequestering G protein-coupled receptors.

  2000influential reference
• A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts

  2000cited by this paper
• Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis.

  2000cited by this paper
• Angiotensin II induces contraction and proliferation of human hepatic stellate cells.

  2000influential reference

• No citing papers are available for this paper.